Clinical Trials Directory

Trials / Completed

CompletedNCT05619939

Impact of Protein Source on Gut Health

Determining the Effect of Dietary Protein Source on Intestinal Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The gastrointestinal (GI) tract is a central hub for human health given its essential role in nutrient absorption, waste production and immunity. Diet is a major contributor to gut health including affecting the incidence and severity of GI disease. This is mediated, at least in part, by the presence of microbiota, a highly diet-dependent biome. In fact, dietary changes are capable of altering bacterial populations and/or microbial metabolism, which in turn, controls the type and abundance of small molecules being produced in the gut, many of which can exert biological effects. Several lines of evidence suggest that dietary protein in particular, can impact gut health. Therefore, this trial will test whether dietary protein type differentially impacts gut function in humans by carrying out a single-blinded randomized cross-over controlled feeding study in healthy individuals. Subjects will be provided with an individualized very low protein diet augmented with pea- or egg white-derived protein supplements, as their major protein source. The impact of consuming pea vs. egg white protein on 1) the fecal metabolome, 2) gut barrier function and 3) gastrointestinal symptoms will be determined.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProtein isolateThe indicated protein isolates will be given to subjects as their major protein source

Timeline

Start date
2023-01-18
Primary completion
2023-04-28
Completion
2023-04-28
First posted
2022-11-17
Last updated
2024-04-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05619939. Inclusion in this directory is not an endorsement.